(firstQuint)Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose Administration.

 Open, one arm, single sequence, 3-period, dose escalating study for healthy volunteers are investigated.

 Ten subjects may be enrolled.

 Subjects receive baseline [11C] sertraline PET.

 Period 1 Subjects receive 5 mg of sertraline every day.

 After 6 day of medication, pharmacokinetic and PET studies are performed.

 Period 2 Subjects receive 25 mg of sertraline every day.

 After 6 day of medication, pharmacokinetic and PET studies are performed.

 Period 3 Subjects receive 50 mg of sertraline every day.

 After 6 day of medication, pharmacokinetic and PET studies are performed.

.

 Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose Administration@highlight

This study aimed to explore the pharmacokinetics and pharmacodynamics of low dose sertraline with [11C] sertraline positron emission tomography (PET) study.

